PharmaCyte Biotech, Inc. Common Stock (PMCB) is a publicly traded Healthcare sector company. As of July 29, 2026, PMCB trades at $0.58 with a market cap of $6.33M and a P/E ratio of 0.18. PMCB moved +0.00% today. Year to date, PMCB is -19.13%; over the trailing twelve months it is -42.60%. Its 52-week range spans $0.57 to $1.90. Rallies surfaces PMCB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for PMCB combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $0.58 |
| Market Cap | $6.33M |
| P/E Ratio | 0.18 |
| EPS | $3.19 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.90 |
| 52-Week Low | $0.57 |
| Volume | 45.87K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $30.66M |
| Gross Margin | 0.00% |
PMCB analyst coverage data. Average price target: $0.00.